tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Immunovant Reports Progress and Financial Results
PremiumCompany AnnouncementsImmunovant Reports Progress and Financial Results
5d ago
Immunovant’s Strategic Advancements and Clinical Progress Justify Buy Rating
Premium
Ratings
Immunovant’s Strategic Advancements and Clinical Progress Justify Buy Rating
5d ago
Immunovant price target lowered to $57 from $58 at Citi
Premium
The Fly
Immunovant price target lowered to $57 from $58 at Citi
5d ago
Immunovant 3M share Block Trade priced at $17.85
PremiumThe FlyImmunovant 3M share Block Trade priced at $17.85
23d ago
Immunovant 3M share Block Trade; price range $17.85-$18.00
Premium
The Fly
Immunovant 3M share Block Trade; price range $17.85-$18.00
23d ago
Immunovant resumed with a Neutral at Goldman Sachs
Premium
The Fly
Immunovant resumed with a Neutral at Goldman Sachs
1M ago
Immunovant price target lowered to $35 from $51 at H.C. Wainwright
PremiumThe FlyImmunovant price target lowered to $35 from $51 at H.C. Wainwright
3M ago
Immunovant’s Strategic Developments and Financial Strength Justify Buy Rating
Premium
Ratings
Immunovant’s Strategic Developments and Financial Strength Justify Buy Rating
3M ago
Immunovant, Inc. Reports Strategic Progress and Financial Results
Premium
Company Announcements
Immunovant, Inc. Reports Strategic Progress and Financial Results
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100